Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
People who have bipolar depression face a 50% lifetime risk of attempting suicide and a 20% risk of death from suicide. Over seven million people in the U.S. are struggling…
Continue Reading
Suicidal Bipolar Depression: Clinical Trial Results of NRX-101 Found Superior Safety and Similar Efficacy Compared to Lurasidone
source: shutterstock.com
In a clinical trial conducted by Dr. Talal and his colleagues, the team compared hepatitis C response rates for 602 patients with opioid use disorders. The trials took place…
Continue Reading
Telemedicine Programs Improve Cure Rates for Hepatitis C vs. Specialist Referral
source: shutterstock.com
As reported in Biopharma Dive, the FDA’s decision to strengthen its authority involving laboratory developed tests (LDTs) has drawn considerable objections from various healthcare groups. However, the Agency has held…
Continue Reading
New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
You may not have heard of spinocerebellar ataxia 4 (SCA4). It is rare and it is a devastating movement disease. SCA4 generally begins when a person is 40 or 50,…
Continue Reading
ICYMI: After a 25 Year Search, a Doctor Discovers the Cause of Spinocerebellar Ataxia 4
source: shutterstock.com
The ALS space looked promising in 2022 after Relyvrio’s approval and a green light for Oalsody in 2023. Then progress stalled a bit in 2024 as a result of Relyvrio…
Continue Reading
Amyotrophic Lateral Sclerosis (ALS): Where Are We Now and Where Are We Going?
Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment | Inside Precision Medicine
Continue Reading
WHATNEXT: Patients Aged 80 to 90 Respond to Standard-of-Care AML Treatment
source: shutterstock.com
Angelman syndrome begins at birth and although symptoms vary, most children exhibit common developmental delays such as: • Infants showing an inability to support their head • Unable to pull…
Continue Reading
A Therapy for Angelman Syndrome Shows Promise, but Adverse Effects Leave Questions
source: shutterstock.com
Unexpected but positive results from a late-stage clinical trial were announced by Cerevel Therapeutics and reported in BioPharma Dive last week much to the surprise of AbbVie, the company that…
Continue Reading
An Investigational Drug to Treat Parkinson’s Produced Surprising Results
source: pixabay.com
On one side of the equation pharmaceutical companies maintain that if drug prices are restricted it will have a negative impact on innovation. Health economists, on the other hand, maintain…
Continue Reading
His Son’s Diagnosis Inspired a New Biotech Company
An American triathlete, Jon Blais, received a diagnosis of amyotrophic lateral sclerosis (ALS) in 2005 when he was 33 years old. The disease is incurable. Jon was told he had…
Continue Reading
EU Researchers Begin Working on an ALS Treatment and Vaccine
source: shutterstock.com
Exa-cel Gene-Edited Therapy Vertex Pharmaceutical recently announced that Health Canada has accepted its New Drug Submission and granted Priority Review for Exa-cel, a gene-edited cell therapy, for the treatment of…
Continue Reading
Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia
source: shutterstock.com
A recent lab study led to an improved understanding of asthma and its mechanisms of action. The co-senior author of the study, Professor Chris Brightling and his colleagues at the…
Continue Reading
Study of Bronchial Asthma Reveals Cause of Cell Damage
source: shutterstock.com
Patients with moderate to severe Crohn’s disease have found quick relief from abdominal pain and stool frequency during the first week of induction therapy according to data analysis published in…
Continue Reading
Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms
source: pixabay.com
Approximately 540,000 individuals in the United States have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD). The disease causes persistent and rapidly accumulating cysts to grow in the patient’s…
Continue Reading
Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
source: shutterstock.com
These efforts led to collaboration by the International Brain pH Project that involves 131 scientists in 105 labs from seven countries. The scientists have identified changes in lactate levels…
Continue Reading
Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders
source: pixabay.com
What is primary immunodeficiency? The Mayo Clinic offers this definition: "PI weakens the immune system and as a result infections or other health problems may occur more often. People with…
Continue Reading
World Primary Immunodeficiency (PI) Week is April 22-29
source: shutterstock.com
Previously, Patient Worthy reported on research focused on the use of a pig kidney in a transplant operation involving a human patient. Richard (Rick) Slayman was released from the hospital…
Continue Reading
Man with Pig Kidney Leaves Hospital, with All Signs Pointing to Success
Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator. (prnewswire.com)
Continue Reading
Xstim, Inc. Receives FDA Approval for Xstim™ Spine Fusion Stimulator
source: shutterstock.com
For decades researchers have had to isolate segments of genes in order to study them. They called the isolated gene a “mini gene.” Ravindra Singh, a biomedical science professor at…
Continue Reading
Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
source: pixabay.com
Duchenne muscular dystrophy (DMD) is an inherited disease that weakens a child’s muscles and eventually spreads throughout the child’s body. DMD is caused by mutations in the gene that helps…
Continue Reading
Gene Therapy Led to “Robust Microdystrophin Expression” in Duchenne Muscular Dystrophy Patient
source: shutterstock.com
A new global study (THAOS NCT00628745) of over 6,000 people who had been diagnosed with ATTR amyloidosis found that almost one in every four patients exhibited cardiac and neurological symptoms.…
Continue Reading
ATTR Amyloidosis: 1 in 4 Patients Experience Neurological and Cardiac Symptoms
source: shutterstock.com
Over 100,000 individuals living in the U.S. are on a waiting list for an organ transplant. An average of 17 people die each day while waiting for a donor organ.…
Continue Reading
Doctors Transplant Genetically Edited Pig Kidney Into 62-Year-Old Man with End-Stage Kidney Disease
source: shutterstock.com
During the past three years two drugs (Aduhelm and Leqembi) that were designed to slow the progression of Alzheimer’s disease, have been approved. A verdict by the FDA on a…
Continue Reading
FDA Puts Off Decision on Approval of a New Alzheimer’s Treatment
According to a recent article in MedicalXpress, scientists have discovered a possible method of treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The study was also published in Science…
Continue Reading
Scientists Find Potential Treatment Approach for FTD and ALS
source: shutterstock.com
Neurological conditions now have the highest rates of disability and ill health worldwide. The Disparity Although more than 80% of the neurological deaths and nervous system disorders occur in lower…
Continue Reading
Study Lists Neurological Disease as the Top Cause of Disability and Illness Around the World